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Abstract
In this communication, we present results indicating a protein isolated from rat liver mitochondrial intermembrane space that is capable of
binding cholesterol and transporting it between the inner and outer mitochondrial membranes. This protein has a molecular weight of 57.5
kDa by SDS-PAGE; however, under native conditions, there is cholesterol-binding capability only as a 115 kDa dimer. Our data show that
this dimeric protein may play a role in the regulation of mitochondrial membrane cholesterol levels, a perquisite for the optimal activity of
inner mitochondrial membrane-associated enzyme complexes. In addition, it appears that this protein is largely responsible for the differences
in membrane cholesterol levels observed in normal and hepatoma mitochondria, a discrepancy which may help to explain the lack of energy
production via oxidative phosporylation in malignant tumor mitochondria.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The enzyme complex responsible for ATP synthesis is
located on the inner mitochondrial membrane [1]. A limiting
factor in this process is the export of ATP from the
mitochondrial matrix space in exchange for import of
ADP from the intermembrane space. The transport of these
highly charged molecules is carried out by the membrane-
bound adenine nucleotide translocase in a 1:1 exchange of
ADP and ATP [2]. In previous studies, it was found that in
tumor cells, the ATP/ADP exchange mechanism malfunc-
tioned in that ADP was exchanged not only with ATP, but
also with ADP in a futile transport cycle [3]. This prevented
efficient ATP efflux from the matrix into the cytosol. This
can explain in part the lack of oxidative phosphorylation and
dependence on higher aerobic glycolysis for energy produc-
tion in certain tumor cells [4]. An Arrhenius plot of adenine
nucleotide translocase activity in normal mitochondria and
tumor mitochondria revealed a 4–5 jC difference in phase
transition point. This discrepancy could be explained by a
membrane composition difference, particularly due to cho-
lesterol [5].
Cholesterol is a critical component of membranes that
influences the fluidity of the lipid bilayer [6]. Specific levels
of cholesterol and other lipids are required for optimal
activity of membrane channels and transporters such as
adenine nucleotide translocase [7]. This restriction of func-
tion to a particular membrane environment points to the
necessity of a regulatory mechanism capable of sustaining
cholesterol composition that is favorable for optimal en-
zyme performance. The importance of such a process for the
mitochondrion is enhanced by its major role in the produc-
tion of ATP for the rest of the cell. Since cholesterol is not
produced in the mitochondrion [8], there must be a transport
mechanism to; (a) deliver cholesterol to, and (b) maintain
cholesterol composition of the inner membrane, where key
oxidative phosphorylation enzymes are located. To deter-
mine the mechanism of this transport, mitochondria were
fractionated into mitoplasts (containing intact inner mem-
branes), outer membranes and intermembrane space pro-
teins. When cholesterol transport was investigated, it was
found that transport between the two membranes was
greatly facilitated by intermembrane space constituents. In
this paper, we identify a mitochondrial cholesterol-binding
protein present in rat liver mitochondria. The molecular
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weight of 57.5 kDa and localization excludes this protein
from other sterol binding proteins such as steroidogenic
acute regulatory protein (StAR), a 37 kDa steroidogenic
tissue mitochondrial protein that facilitates the delivery of
cholesterol to cytochrome P450 on the inner membrane [9–
11]; metastatic lymph node protein, MLN64 [12], a StAR
homologue and late endosomal cholesterol-binding protein;
SCP, an intracellular sterol carrier protein [13]; and other
cholesterol-binding proteins [14,15]. The protein studied in
this communication is capable of binding cholesterol in the
115 kDa molecular weight region, indicating a probable
dimer. In addition, the cholesterol-binding function of this
protein was further confirmed by the fact that in our
isolation and purification procedures this protein was
purified in the final step by the use of cholesterol affinity
chromatography.
2. Materials and methods
2.1. Isolation of rat liver mitochondria
Male Sprague–Dawley rats were sacrificed and the livers
were promptly excised, weighed and placed in a 5 volume
of homogenizing buffer (2 mM HEPES, 220 mM mannitol,
70 mM sucrose, and 1 mM EDTA at pH 7.4) at 4 jC [2,3].
The tissue was briefly blended and homogenized using a
Dounce motorized homogenizer. The homogenate was cen-
trifuged at a low speed (3000 g) to separate the unbroken
cells, red blood cells, cell membranes, nuclei, etc. The pellet
was re-suspended in homogenizing medium and homogen-
ized and centrifuged at 3000 g two more times to quan-
titatively remove all mitochondria. The combined su-
pernatants were centrifuged at 9000 g for 15 min. The
pellet was saved and washed with 5 volumes of homoge-
nization buffer and centrifuged at 13,000 g for 10 min.
This pellet was again washed with homogenization buffer
and centrifuged at 3000 g for 5 min to remove contam-
inants as before. This supernatant was centrifuged at
13,000 g for 20 min. The final pellet was re-suspended
in 2–3 volumes of 0.25 M sucrose, pH 7.4. The isolated
mitochondria were washed repeatedly after each step in
order to obtain pure mitochondria without contaminants
from other cellular components [2], which has been proven
to be negligible by Hovius et al. [16]. Hepatoma mitochon-
dria were similarly isolated as previously described [5].
2.2. Isolation of intermembrane space proteins
To avoid the disruption of the lipid composition of outer
membranes by digitonin, subfractionation of mitochondria
carried out by the swell–shrink–sonicate procedure of
Hovius et al. [16]. Mitochondria were centrifuged at
13,000 g for 15 min and the pellet was suspended in 2
volumes of an isotonic 0.25 M sucrose/EDTA/HEPES
buffer. To this suspension, doubly distilled water was added
to dilute the sucrose concentration to 0.15 M to swell the
mitochondrial membranes. The mixture was mildly soni-
cated for 20 s (intervals of 6–7 s using a Bronson sonicator)
to promote the breakage of the outer mitochondrial mem-
brane. After sonication, 1.0 M sucrose was added to obtain a
final concentration of 0.25 M sucrose. The suspension was
then centrifuged at 13,000 g for 15 min. The pellet
contains the mitoplasts, while the supernatant has fragments
of the outer membrane and the intermembrane space con-
tents. The supernatant was centrifuged at 100,000 g for 1
h. The supernatant from this spin contains the soluble
intermembrane space proteins.
2.3. Purification with affinity column chromatography
Ammonium sulfate fractionation was performed on the
intermembrane soluble proteins for the following satura-
tions: 0–35%, 35–55%, and 55–75%. The 35–55% frac-
tion was frozen, thawed and then re-fractionated to 35–
55%. This new fraction was suspended in 20 mM sodium
phosphate buffer (pH 7.4) and saved for separation on a gel
filtration column. The partially purified protein was placed
on an agarose (0.5 M, 200–400 mesh, Bio Rad) gel column
(100 1.5 cm) and eluted with a 20 mM sodium phosphate
buffer (pH 7.4) at 4 jC. Fractions were collected and
measured for presence of protein by UV spectrophotometric
analysis at 280 nm as well as the BCA method (Pierce) [17]
for determining protein concentration. Peaks were plotted
and molecular weights were estimated by calculating the
average elution values of standard molecular weight pro-
teins (BSA and cytochrome c).
Cholesterol affinity chromatography was used to further
purify this protein. Cholesteryl-3-hemisuccinate (5-choles-
ten-3h-ol-3-hemisuccinate) (Sigma) was attached to free
amino groups of 1,6-diaminohexyl (EAH) Sepharose 4B
(Pharmacia) via the carbodiimide coupling method as
described [18]. Twenty-five milliliters of EAH Sepharose
4B was added to 50 ml of 70% dioxane containing 2.43 g
cholesteryl-3-hemisuccinate (10 mM), pH 4.5. 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide was added to a final
concentration of 0.1 M and the mixture was stirred over-
night at 30 jC. The gel slurry was washed repeatedly to
remove excess ligand; with 250 ml 1,4 dioxane, 500 ml 80%
methanol, 500 ml distilled water. The gel was packed in
binding buffer (20 mM sodium phosphate, pH 7.4). Protein
fractions from gel filtration were added to the column and
first washed with the binding buffer for approximately 25–
30 ml until no discernable protein was detected by UV 280
nm. Due to the insolubility of cholesterol in aqueous
solution, a competitive elution of proteins with free ligand
was not feasible. To overcome this, a change in ionic
strength was used to elute proteins retained on the column
[19]. A linear gradient of 0–500 mM potassium chloride
was applied to elute cholesterol-binding proteins as de-
scribed in the manner of Kuwada et al. [19] for purification
of cytochromes P-450SSC. Protein eluted in the region of
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100–150 mM KCl which was confirmed by examining
fractions for OD 280 nm.
2.4. Binding of [3H] cholesterol and sucrose density
gradient
[3H] cholesterol (NENuclear, 47.9 Ci/mmol) was dis-
solved in chloroform and air-dried in a glass test tube. The
gel filtration fraction corresponding to the largest molecular
weight peak (115 kDa) was added and the mixture was
incubated overnight at 4 jC. This sample was then placed
on a sucrose density gradient in a centrifuge tube (a linear
gradient from 5% to 25% sucrose in 20 mM sodium
phosphate buffer). A standard sample of 5 mg/ml BSA
and 2 mg/ml cytochrome c was added to another identical
tube for direct comparison. The tubes were centrifuged at
120,000 g for 22 h. 0.5 ml fractions were collected
starting from the bottom of the centrifuge tube and 0.1 ml
aliquots were added to scintillation fluid (Liquiscent,
National Diagnostics) for detection of radioactivity by
scintillation counting. The absorbance at 280 nm was
determined in the fractions to detect the presence of protein
and the samples were run on SDS-PAGE to determine the
molecular weight and purity of the protein.
2.5. Cholesterol transport assays
Cholesterol transport between mitochondrial membranes
was monitored in the following manner: the three compart-
ments on the mitochondrion (mitoplast, outer membrane,
and intermembrane space protein) were isolated by differ-
ential centrifugation as stated previously. The assays were
performed with the mitoplast and outer membranes kept at
the same amount of protein (f 200 Ag) as well as varying
amounts of membrane protein concentration up to 5-fold
more inner membrane to that of outer membrane. The
former ratio containing significantly more outer mem-
brane/inner membrane, and the latter ratio resembling a
more physiological relationship. The two membrane frac-
tions were separated by differential centrifugation and
suspended in 5 volumes of 0.25 M sucrose/EDTA/HEPES.
The tubes were centrifuged at 3000 g for 5 min to wash
the membranes. [3H] Cholesterol was added to the mitoplast
fraction and incubated at 4 jC for 1 h. This is centrifuged at
3000 g to remove all unbound cholesterol and the pellet is
resuspended. For experiments examining the effect of pro-
tein concentration on cholesterol transfer, labeled mitoplasts
were incubated with outer membranes and the intermem-
brane space proteins ranging from 0 to 240 Ag for 40 min.
For experiments on the effect of time; the labeled mitoplasts
were incubated with outer membranes and 120 Ag of the
intermembrane space protein for times ranging from 0 to 60
min. The tubes were then centrifuged at 3000 g again and
the pellet (mitoplast) is removed. The supernatant, consist-
ing of the intermembrane space proteins and the outer
membrane is centrifuged by a Beckman Airfuge (85,000
rpm) for 30 s. The pellet from the high-speed spin contains
the outer membrane. The radioactivity present in the outer
membrane fraction shows the magnitude of cholesterol
transfer from the inner membrane to the outer membrane
dependent on time or amount of intermembrane space
protein. This assay was also similarly performed by initially
labeling the outer membrane to monitor transfer from the
outer to inner membrane. To determine the efficiency of the
membrane separation and purity of the two membranes, the
activities of two specific enzymes, monoamine oxidase
(MAO) from the outer membrane, and cytochrome oxidase
from the inner membrane were measured in each membrane
fraction. Briefly, the oxidative deamination of 14C-phenyl-
ethylamine was monitored to determine the level of MAO
activity present in the inner membrane fractions after the
transport assay was performed [20]. Any activity present in
this inner membrane fraction was compared with that of the
outer membrane fraction as a gauge for determining the
level of contamination of the mitoplasts by the outer mem-
branes. Conversely, cytochrome oxidase activity [21] was
measured in the outer membrane fraction and compared to
that of the inner membrane fraction to determine the extent
of inner membrane contamination during the transport
assay. From these determinations, the membrane cross-
contamination was generally in the range of 3.97–5.66%
of outer membrane in the inner membrane fraction and up to
6.2–8.32% of inner membrane in the outer membrane
fraction.
2.6. Electrophoretic analysis
Fractions from the gel filtration column and sucrose
density gradient run were examined on denaturing and
non-denaturing polyacrylamide gel systems. A 12% SDS
polyacrylamide gel was prepared by the method of Laemmli
[22]. To visualize the functional native form of the isolated
protein, a non-denaturing, native, electrophoresis procedure
[23,24] was used as well. Native PAGE gels were made at
varying percentages of acrylamide from 4% to 10%. The
upper chamber buffer used was 42.6 mM Tris and 46.4 mM
glycine at pH 8.4. The lower chamber buffer was 239 mM
Tris at pH 8.1. All native gels were run at 60 V for several
hours according to percentage of acrylamide in a 4 jC room
to maintain the native form of the proteins.
To permit visualizing protein dimers on a native gel as
monomers on a denaturing SDS gel, two-dimensional gel
electrophoresis was carried out by excising a single gel lane
from a native gel and placing it horizontally along the
stacking gel of a 12% SDS-PAGE gel. Gels were stained
with Coomassie Brilliant Blue and Bio Rad Silver stained
according to protocol (Bio Rad).
2.7. Colorimetric determination
Cholesterol content of membranes was expressed in
terms of micrograms of cholesterol per milligram of protein.
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Total amounts of cholesterol were determined by the
method of Zlatkis and Zak [25]. Lipids were extracted from
inner and outer membrane fractions by addition of 0.5 ml
methanol and 0.5 ml chloroform to a sample volume of
0.2–0.3 ml followed by vortexing for 1 min. One milliliter
of distilled water was added followed by vortexing for 2
min. The mixture is centrifuged in a tabletop centrifuge at
maximum speed for 5 min and the aqueous layer is
removed. The chloroform layer is separated into 0.2 and
0.3 ml fractions and dried under N2 gas. The dried lipids
were dissolved in 0.1 ml glacial acetic acid and 2 ml of the
cholesterol reagent o-phthaldialdehyde (0.5 mg/ml acetic
acid) was added. After mixing well, 1 ml concentrated
sulfuric acid was added and the tubes were vortexed and
incubated at room temperature for 10 min. The OD 550 was
recorded and compared to a standard curve of 10–100 Ag
cholesterol. Protein concentration was determined by the
BCA method [17].
3. Results
3.1. Cholesterol contents
To investigate the differences in ATP translocation
between normal and tumor mitochondria, the membrane
cholesterol composition of mitochondria from both normal
and tumor cells was compared. There were generally higher
levels of total cholesterol (Ag cholesterol/mg protein) in
tumor mitochondria (Morris hepatomas 7800, 16, 5123D,
and 7777) than in normal mitochondria (Table 1). Moreover,
the elevated levels of cholesterol seem to be correlated to the
degree of malignancy of the tumor in question. The most
malignant tumors, Morris hepatoma 7777, have nearly 5-
fold more cholesterol than normal mitochondria whereas
less malignant tumors, such as Morris hepatomas 16 and
7800, only show an increase of approximately 2-fold.
Intermediate growth rate tumors (Morris hepatoma 5123D)
Table1
Morris hepatoma mitochondrial cholesterol contents (Ag cholesterol/mg
protein)
Whole
mitochondria
Outer
membrane
Inner
membrane
Liver 8.74F 1.0 36.6F 4.3 10.1F 2.6
Hepatoma 16 12.84F 4.0 37.4F 2.4 18.8F 3.8
Hepatoma 7800 17.5F 1.5 27.5 17.25
Hepatoma 5123D 25.5F 5.2 ND ND
Hepatoma 7777 43.1F 9.5 43.0 28.75
Cholesterol content in membranes of normal (liver) and various Morris
hepatoma cell lines expressed in micrograms of cholesterol per milligram of
protein. Tumor cell lines are listed in order of increasing malignancy
(hepatoma 16 is the slowest growing cell line, hepatomas 5123D and 7800
are intermediate-growing cell lines, and hepatoma 7777 is the most
malignant cell line). Results are averages (F standard errors) from four
determinations for normal liver mitochondria, and duplicates for hepatoma
mitochondria. (ND, not determined).
Fig. 1. Cholesterol transport between the inner and outer membranes in the
presence of intermembrane space protein. (A) The cholesterol transport is
enhanced by the intermembrane space proteins. There is a linear
dependence of transport on the amount of protein presence from 0 to 60
Ag protein. As the protein is increased further, the slope decreases and
becomes negative. This may indicate that at certain levels of protein,
cholesterol is removed from the outer membrane. This assay was done over
the course of 40 min. (B) Cholesterol transport is dependent on inter-
membrane space proteins and time. Cholesterol accumulation in the outer
membrane fractions is dependent on protein (n), while there is little
difference in transport where no protein is present (.). In addition, as time
increases there appears to be removal of cholesterol from the outer
membrane in samples with protein. Samples without protein show little
difference in cholesterol binding over time. (C) Cholesterol transfer from
the outer membrane to the inner membrane is protein- and time-dependent
(n). From 0 to 20 min, cholesterol delivery to the inner membrane increases
at a near linear rate, but becomes stagnant as the incubation time increases
(20–60 min). There is no change in the rate of transfer when no protein is
present (.). The quality of separation of membranes was confirmed by
measuring the activities of marker enzymes MAO, from the outer
membrane, and cytochrome oxidase, from the inner membrane, in both
the inner and outer membrane fractions. It was found that the outer
membrane contamination to the inner membrane fraction, as determined by
MAO activity, was in the range of 3.97–5.66%. Values of 6.2–8.32% were
obtained for the contamination of inner membranes to the outer membrane
fraction, judged by cytochrome oxidase activity.
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have approximately 3-fold higher levels than normal mito-
chondria. When the membranes were fractionated, it was
determined that cholesterol levels per mg membrane protein
in the inner membrane fraction increased in tumor mem-
branes, where they exhibited as much as a 3-fold increase
over normal inner membranes (Table 1). This is of impor-
tance to the potential function of membrane-associated
enzymes related to oxidative phosphorylation which are
located on the mitochondrial inner membrane. Again, this
increase appears to be directly proportional to the relative
malignancy of tumor cell lines examined, with the most
malignant tumor, hepatoma 7777, containing approximately
1.5-fold more cholesterol than slow-growing tumor cell line
inner membranes and 3-fold more cholesterol than in
normal mitochondrial inner membranes. Results from outer
membranes show only slight increases in tumor mitochon-
dria. These data can support the previously reported differ-
ences in ATP/ADP translocation between normal and tumor
mitochondria [3] and lead to the pursuit of a mechanism
whereby membrane cholesterol composition can be main-
tained or altered.
3.2. Cholesterol transport between mitochondrial mem-
branes is enhanced by an intermembrane space protein
Cholesterol transport from the inner membrane to the
outer membrane was examined as a function of time and
amount of protein (Fig. 1A and B). There was a low level of
transport observed when no protein was added to the assay,
which can be attributed to contact sites formed between the
two membranes as a result of the in vitro assay. At small
amounts of protein (0–60 Ag) cholesterol transport to the
outer membrane was linearly dependent on the protein
concentration and increased by 7-fold over baseline levels
(Fig. 1A). Cholesterol transport leveled and decreased
slightly as the intermembrane space protein increased (60–
240 Ag). This protein-dependent transport mechanism is
capable of relocating cholesterol to and, with higher amounts
of protein, away from the outer membrane. These results
cannot be explained by membrane contamination during the
transport assay because only a small percentage of contam-
ination was observed as indicated (Section 2.5). Transfer was
also measured as a function of incubation time (Fig. 1B).
Fig. 2. Identification of a cholesterol-binding protein (A) The 35–55% protein fractions were incubated with [3H] cholesterol and partially purified by gel
filtration with Bio gel A-0.5 m 200–400 mesh beads (Bio Rad). Proteins were eluted from the column with 20 mM sodium phosphate buffer (pH 7.4).
Fractions from the column were tested for radioactivity (the presence of cholesterol) by scintillation counting and protein by measuring the absorbance at 280
nm. It was found that there was a single radioactive peak (Fraction 18 contained 4.500 counts) which corresponded with a protein peak of approximately 115
kDa. There was only one radioactive peak, indicating that the cholesterol-binding protein was in this 115 kDa fraction. (B) In an effort to purify this protein, gel
filtration was repeated in the absence of radioactive cholesterol. Protein was isolated from the intermembrane space of rat liver mitochondria by ammonium
sulfate fractionation. The 35–55% fraction was eluted from the gel filtration column with 20 mM sodium phosphate buffer. A duplicate standard run was
carried out with Dextran (f 106 kDa), BSA (66 kDa), cytochrome c (12.5 kDa), and DNP Alanine (255 Da). Elution volumes for these standard proteins are
shown. The average elution volumes were calculated and used to determine the molecular weights of the major peaks. Peak A was determined to be f 117
kDa, while peak B was determined to be f 58 kDa. Further experiments including affinity chromatography, sucrose density gradient, and two-dimensional
electrophoresis were performed using protein from gel filtration peak A.
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There was little difference in the amount of cholesterol
detected over time (0–60 min) when no protein was added
to the assay. After 120 Ag protein was added the cholesterol
transport increased linearly over the period of 0–20 min
exhibiting a 5-fold increase but decreased to near baseline
levels as the incubation time increased from 20 to 60 min.
These data point to dynamic protein-dependent mechanism
by which cholesterol can be transported to the outer mem-
brane and removed from it. Transfer from the outer mem-
brane to the mitoplast was measured as well (Fig. 1C).
Although similar to Fig. 1B, cholesterol transfer to the inner
membrane was immediate, and increased at a near linear rate
for the first 20 min of incubation time with the cholesterol-
binding protein. However, as this incubation time increased
from 20 to 60 min, there was little difference and transport
remained at a plateau. These results indicate the transport of
cholesterol mediated by this protein proceeds in both direc-
tions and the extent is condition-dependent. The information
Fig. 3. Cholesterol affinity chromatography. Protein from the major peak of
the gel filtration run (Peak A, Fig. 2) was applied to a cholesterol affinity
chromatography column. The cholesterol-binding protein was retained on
the matrix and all other non-binding proteins were eluted with 20 mM
sodium phosphate buffer (pH 7.4) for approximately 30 ml until no
significant protein could be detected by the measurement of OD at 280 nm.
Once all contaminating proteins had been eluted (Peak A), the cholesterol-
binding protein was desorbed from the column by the addition of a linear
gradient of 0–500 mM KCl prepared in 20 mM sodium phosphate buffer.
The gradient yielded a single protein peak which eluted from approximately
100–150 mM KCl (Peak B). There were no additional peaks observed,
which indicates a clean separation and purification of this cholesterol-
binding protein.
Fig. 4. SDS-PAGE of cholesterol-binding protein. The 115 kDa cholesterol
binding fraction from gel filtration was examined on a denaturing
electrophoresis system (lane A). The partially purified protein existed as
a 57.5 kDa band on SDS gels, indicating the presence of a native dimer
form. Cholesterol affinity chromatography was performed to further purify
this protein (lane B). Affinity chromatography yielded a single 57.5 kDa
band providing a means of purifying this protein to homogeneity.
Fig. 5. Two-dimensional electrophoresis. (A) The top lane (first dimension)
is cut from a native non-denaturing gel run of the peak (115 kDa) fraction
from gel filtration. The two major bands in this lane are the 115 kDa dimer
and the 57.5 kDa monomer of the protein. This lane was placed on a SDS-
PAGE gel and run under denaturing conditions with a standard protein
marker. In the denaturing system, both bands migrate to the same position
at 57.5 kDa. This provides evidence that the 115 kDa cholesterol-binding
species from gel filtration is in fact a dimer of a 57.5 kDa protein. The
native lane is from a 7% acrylamide non-denaturing run. (B) Native gel
standard curve. The native gels were run at varying acrylamide percentages
(from 5% to 10%). Migration distances of standard proteins BSA (132, 66
kDa), egg albumin, EA, (90, 45 kDa), and pepsin (34.7 kDa) were taken for
each gel. The cm/h of each protein species from the different gels (5–10%)
was calculated and plotted against the percentage of acrylamide (not
shown) to determine the slope (cm/h/% acrylamide) of each protein. This
value was plotted against the log of the molecular weight of the known
proteins. It was calculated that the cm/h/% acrylamide for the sample
protein was  0.260. This value was used to calculate the log MW from the
line of best fit, y= 0.5859x  3.0546, to find the molecular weight. The log
Mw of the monomer is 4.77, which gives a molecular weight of 58.9 kDa.
The cm/h/% of the dimer species is  0.080, which corresponds to a
molecular weight of 118.3 kDa.
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presented in Fig. 1 shows cholesterol transfer when the
membrane proteins of both the inner and outer membranes
were kept equal (f 200 Ag). When this ratio was varied up to
1:5 (outer membrane/inner membrane), which more closely
resembles in vivo conditions, protein-dependent cholesterol
transport was also evident and similar.
3.3. Identification of a cholesterol-binding protein
The intermembrane space contents of mitochondria from
male Sprague–Dawley rats were isolated in an effort to
identify a cholesterol-binding protein. From 1 g of liver, we
isolated 7.3F 0.9 mg protein from whole mitochondria,
1.92F 0.08 mg protein from the crude intermembrane space
fraction, 0.74F 0.05 mg protein from the 35% to 55%
ammonium sulfate fraction, and 0.160F 0.014 mg of the
cholesterol-binding protein. To identify the cholesterol-
binding protein, proteins were isolated by ammonium sul-
fate fractionation and incubated with [3H] cholesterol and
applied to a gel filtration column. When the fractions were
tested for radioactivity, the 35–55% ammonium sulfate
fraction of the intermembrane space proteins produced a
protein peak that corresponded to the single radioactive
peak (Fig. 2A). The size of this protein was estimated to be
115 kDa by running known molecular weight standards
(BSA and cytochrome c). No other protein peaks in the
elution profile correlated with a radioactive peak, which
indicates that there was a single 115 kDa species in the
intermembrane space that could bind cholesterol. In an
effort to purify this protein, the gel filtration run was
repeated and the 115 kDa peak (Fig. 2B) was saved for
further purification and characterization.
To further purify the cholesterol-binding protein, frac-
tions corresponding to the 115 kDa peak from gel filtration
were applied to a cholesterol affinity chromatography col-
umn. Any contaminating proteins were eluted with 20 mM
sodium phosphate buffer and the remaining proteins bound
to the gel were desorbed from the column by a linear 0–500
mM KCl gradient. The elution profile shows a single peak
eluted between 100 and 150 mM KCl corresponding to the
purified cholesterol-binding protein (Fig. 3). The fact that it
was possible to elute this protein with increasing salt con-
centration without the addition of a strong denaturant, or a
chaotropic reagent, indicates that this protein binds choles-
terol via non-covalent interactions.
3.4. Analysis of cholesterol-binding protein by SDS, native,
and two-dimensional electrophoresis
The fraction from gel filtration corresponding to the
radioactive peak was examined on a SDS-PAGE gel (Fig.
4, lane A). This fraction determined to be 115 kDa by gel
filtration appeared as a 57.5 kDa band on the denaturing gel.
SDS gels of the 100–150 mM KCl peak eluted from
cholesterol affinity chromatography yielded a single 57.5
kDa band showing the successful purification of a choles-
terol-binding protein (Fig. 4, lane B). In addition, the data
showing a single 57.5 kDa band present on denaturing gels
revealed the possibility that this protein may be a functional
dimer. To investigate this further, a two-dimensional gel
system using a non-denaturing gel method and SDS-PAGE
was used. The protein appeared as a doublet on the native
gels with molecular weights 115 and 57 kDa (Fig. 5A, top).
The lane was excised from the native gel and carefully
Fig. 6. Radioactive cholesterol binding assay. [3H] cholesterol was added to the peak sample from gel filtration and placed on a 5–25% sucrose density
gradient. The tube was centrifuged at 200,000 g for 22 h and the fractions were collected starting from the bottom. Each fraction was measured for
radioactivity using a liquid scintillation counter. For comparison, a standard tube was prepared with BSA (132 kDa dimer, 66 kDa monomer) and cytochrome c
(12.5 kDa) under identical conditions as the sample tube. Points on the graph represent the location of different proteins in the sucrose elution profile. The
radioactive peak corresponds to the molecular weight of the cholesterol-binding protein dimer (roughly 120 kDa). There is a lack of cholesterol binding in the
50–60 kDa region, corresponding to the monomer species of the cholesterol-binding protein. This particular protein can only bind cholesterol when present as
a high molecular weight dimer.
A.M. Campbell et al. / Biochimica et Biophysica Acta 1567 (2002) 123–132 129
placed on a SDS gel. Both the high and low molecular
weight bands from the native gel appeared as a single 57.5
kDa band on the SDS gel (Fig. 5B, bottom). This proves
that this cholesterol-binding protein exists as 115 kDa dimer
under native conditions.
3.5. Cholesterol-binding in a high molecular weight region
To further emphasize the nature of cholesterol binding,
sucrose density gradient separation was used. The protein
peak from gel filtration was incubated with [3H] cholesterol
and placed on a 5–25% sucrose density gradient. After
centrifugation, the fractions were collected, counted for
radioactivity, and examined on SDS gels. The elution profile
of cholesterol counts showed a single radioactive peak that
corresponds to a molecular weight of f 120 kDa (Fig. 6,
bottom). PAGE gels of the fractions show a 115 kDa protein
band corresponding to this radioactive peak (Fig. 6, top).
There is no radioactivity in fractions corresponding to the
57.5 kDa bands. This confirms that cholesterol binding is
limited to the high molecular weight dimer (115 kDa)
rendering the monomer non-functional.
4. Discussion
We have identified a 115 kDa protein in the intermem-
brane space of rat liver mitochondria which is capable of
binding cholesterol and facilitating the transport of choles-
terol between the inner and outer membranes. The purifi-
cation of this protein by cholesterol affinity chromatography
confirms the cholesterol-binding function. We have shown
that this protein, with a molecular weight of 57.5 kDa on
SDS gels, must be present as a dimer in order for cholesterol
binding to occur; there is no apparent cholesterol binding to
the monomer.
Many years ago, it was shown that many malignant
tissues rely more heavily on glycolysis for production of
energy, creating an energy drain on surrounding healthy
tissues [26,27]. A contributing factor to this is the function
of the mitochondrial ATP/ADP exchanger, the adenine
nucleotide translocase. Normal mitochondria exchange
adenine nucleotides across the inner mitochondrial mem-
brane in a 1:1 process (one ATP for one ADP) [2]. However,
in tumor mitochondria, there is a lack of normal exchange,
ATP is not exclusively and efficiently removed from the
matrix space, and hence cannot be transported to the rest of
the cell [3]. When an Arrhenius plot was constructed for
adenine nucleotide transport activity a breakpoint difference
of 4–5 jC in tumor mitochondria was observed [3]. This is
due to the different lipid compositions of the tumor mito-
chondrial membranes, particularly an elevated level of
cholesterol [5]. To investigate this phenomena, the mem-
brane cholesterol composition of mitochondria from normal
cells as well as several tumor cell lines was compared. This
communication and others [5,28] show generally higher
levels of cholesterol (Ag per mg protein) in tumor mitochon-
dria than that of normal mitochondria. The abnormally high
levels of cholesterol present in the inner membranes of these
tumor cell mitochondria will have a profound affect on the
function of membrane-associated enzyme complexes and
therefore the energy-producing capacity of mitochondria.
This is primarily due to the fact that enzymes integral to the
oxidative phosphorylation process such as adenine nucleo-
tide translocase require an optimal level of membrane
cholesterol to ensure efficient enzyme activity [7]. When
mitochondria are enriched with excess cholesterol in vitro
[29], cholesterol levels in normal mitochondria are greatly
increased to resemble those of tumor cell mitochondria
[5,28]. However, when given oxidizable substrates during
incubation, cholesterol was gradually depleted from the
inner membrane and transported back to the outer mem-
brane (unpublished results). In contrast, when tumor mito-
chondria are cholesterol-enriched, cholesterol remains in the
inner membrane at high levels. This information and the
compartmentalization of cholesterol in the cell lead to the
necessity of a regulatory mechanism responsible for main-
taining the correct cholesterol composition in the inner
mitochondrial membrane.
We have identified a protein from the intermembrane
space that when in its native dimer form possesses choles-
terol-binding ability and can facilitate cholesterol transfer
between the inner and outer mitochondrial membranes. The
data presented here indicate that this is a fluid transfer in that
cholesterol can be transported from the inner membrane to
the outer membrane and, over time, excess amounts can be
removed from it. Similarly, when the movement from the
outer membrane (OM) to inner membrane (IM) was moni-
tored, cholesterol was transferred to the inner membrane at a
relatively rapid rate, and over time, the level of cholesterol
remains high. The difference in transfer between both direc-
tions (IM to OM, and OM to IM) can be explained in part by
the knowledge that the rate of cholesterol transfer is depend-
ent more on the nature of the acceptor membrane rather than
the removal of cholesterol from the donor membrane [30].
The inherent dissimilarities between the inner and outer
mitochondrial membranes may affect this rate, explaining
the slightly different results presented here for each directions
of transport. In addition to the biochemical uniqueness of
each membrane, there are significant differences in the
amount of each membrane present in intact mitochondria.
This discrepancy does not have a major effect as cholesterol
transfer was observed when the ratio of membrane proteins
was kept equal (1:1, outer membrane/inner membrane) and
varied to a more in vivo ratio (1:5, outer membrane/inner
membrane). Transfer was evident in each case (data not
shown). In addition, the dynamic nature of this transfer
mechanism appears to support the theory of regulating
membrane cholesterol for optimal enzyme function.
Other mitochondrial cholesterol-binding proteins have
been identified, such as the peripheral benzodiazepine
receptor, PBR [31] and StAR [11]. PBR, an 18 kDa outer
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mitochondrial membrane protein, is expressed in most
tissues but primarily in those involved in steroid production
and has been proven to be most important to the trans-
portation of cholesterol in steroidogenic mitochondria [15]
and linked to the mechanism of proliferation of various
cancer cell types [32]. PBR has also been shown to exist in
elevated levels in liver tumors [33], a fact that, when
included with the results of this communication, add to
the role of cholesterol transport in the altered cellular
function of tumor cells. StAR has been proven to be
necessary for delivery of cholesterol to the cholesterol
side-chain cleavage complex on the inner mitochondrial
membrane during hormone synthesis in steroidogenic tis-
sues [34]. Unconfirmed models of the mechanism of cho-
lesterol transfer include: a cholesterol desorption model in
which the outer membrane-associated protein can facilitate
transfer of cholesterol to the inner membrane, and a shuttle
hypothesis which involves the repeated protein-bound cho-
lesterol transfer from the outer membrane to the target
enzyme complex on the inner membrane [35]. This latter
model has been shown to be unlikely for StAR due to the
fact that truncated forms of the protein (without a mitochon-
drial targeting presequence) still result in increased steroido-
genesis [8] as well as the observation that the imported
mature StAR protein is not capable of transporting choles-
terol [36]. Although the molecular weight, localization, and
preliminary N-terminal sequence data (unpublished results)
exclude this protein from other known cholesterol-binding
proteins; including SCP-x [37], StAR [9], PBR [15],
MLN64 [12], SCP [13], and NCP1 [14], these findings
can provide perspectives about the mechanism of action
of the protein presented in this communication. The local-
ization of this protein in the intermembrane space of mito-
chondria leads to the possibility of a carrier model where the
protein can shuttle cholesterol from one membrane to the
other. It is known, however, that there are membrane contact
sites between the two mitochondrial membranes [38]. This
protein may bind cholesterol and provide a means to aug-
ment these contact sites permitting the transfer of cholesterol
between membranes. An important observation on this
protein is the fact that only a dimerized form is capable for
cholesterol binding, a process which may be itself ATP-
dependent. This could lead to the possibility of a lack of
dimerization and therefore a lack of a functional cholesterol
transporter in tumor cells where high energetic states do not
exist. Preliminary unpublished observations show that
this protein is also present in tumor mitochondria though
proper function in tumor mitochondria seems to be
lacking. We are currently studying both cholesterol bind-
ing and transportation in tumor mitochondria and
whether a correlation exists between the degree of mali-
gnancy of the tumors and a lack of normal activity of the
protein.
In conclusion, our findings indicate that an intramito-
chondrial cholesterol-binding protein plays a key role in
maintaining proper membrane cholesterol composition that
is required for optimal capacity of the oxidative phosphor-
ylation process of energy production in normal liver tissues.
The sequencing and molecular cloning of this protein is
underway in an effort to further elucidate the mechanism of
action of this protein-dependent cholesterol transfer.
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